Skip to content

PACS Group PACS Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

The Ensign Group logo
The Ensign GroupENSG
Brookdale Senior Living logo
Brookdale Senior LivingBKD
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
Tenet Healthcare logo
Tenet HealthcareTHC
HCA Healthcare logo
HCA HealthcareHCA
American Healthcare REIT logo
American Healthcare REITAHR

Other financials

Income statement

See full
Revenue$1.4B+11.2%
Gross profit$346.0M+36.5%
Operating income$120.0M+149%
Net income$80.7M+183%
EPS (diluted)$0.50+194%

Balance sheet

See full
Cash & equivalents$273.7M-5.8%
Total debt$3.5B-3.2%
Total equity$1.0B+38.2%
Total assets$5.7B+3.1%

Cash flow

See full
Operating cash flow$236.3M+57.3%
CapEx$21.8M+23.2%
Free cash flow$214.5M+61.9%

Valuation

See full
Market cap$5.91B+189%

Profitability

See full
Gross margin23%+3.7pp
Operating margin7%+4.6pp
Net margin4.5%+3.4pp
FCF margin7.7%

Returns & leverage

See full
Return on equity27.3%+15.8pp
Debt / equity3.3×-1.4×
Current ratio0.0×

Where this comes from

Reported directly by PACS Group in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: PACS Group’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about PACS Group's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PACS Group's common stock, shares authorized (in shares)?
PACS Group (PACS) reported common stock, shares authorized (in shares) of $1.25B in Q1 2026.
How has PACS Group's common stock, shares authorized (in shares) changed year-over-year?
PACS Group's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $1.25B to $1.25B.
What is the long-term trend for PACS Group's common stock, shares authorized (in shares)?
Over 2 years (2023 to 2025), PACS Group's common stock, shares authorized (in shares) has grown at a -86.1% compound annual growth rate (CAGR), from $64.36B to $1.25B.